Schonfeld Strategic Advisors LLC Lowers Position in LifeStance Health Group, Inc. (NASDAQ:LFST)

Schonfeld Strategic Advisors LLC decreased its stake in shares of LifeStance Health Group, Inc. (NASDAQ:LFST - Free Report) by 85.9% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 88,500 shares of the company's stock after selling 538,200 shares during the period. Schonfeld Strategic Advisors LLC's holdings in LifeStance Health Group were worth $652,000 at the end of the most recent quarter.

Several other institutional investors have also bought and sold shares of the stock. Blue Trust Inc. boosted its holdings in LifeStance Health Group by 124.4% during the 4th quarter. Blue Trust Inc. now owns 3,828 shares of the company's stock worth $27,000 after acquiring an additional 2,122 shares during the last quarter. LPL Financial LLC grew its position in LifeStance Health Group by 6.0% in the 4th quarter. LPL Financial LLC now owns 37,584 shares of the company's stock worth $277,000 after purchasing an additional 2,127 shares in the last quarter. MetLife Investment Management LLC increased its stake in LifeStance Health Group by 6.8% in the 4th quarter. MetLife Investment Management LLC now owns 85,914 shares of the company's stock valued at $633,000 after buying an additional 5,492 shares during the last quarter. Legal & General Group Plc lifted its position in shares of LifeStance Health Group by 4.6% during the 4th quarter. Legal & General Group Plc now owns 134,557 shares of the company's stock worth $992,000 after buying an additional 5,917 shares in the last quarter. Finally, Rhumbline Advisers boosted its stake in shares of LifeStance Health Group by 4.5% in the 4th quarter. Rhumbline Advisers now owns 195,581 shares of the company's stock worth $1,441,000 after buying an additional 8,487 shares during the last quarter. Institutional investors own 85.50% of the company's stock.

Insiders Place Their Bets

In related news, insider Lisa K. Miller sold 18,845 shares of the company's stock in a transaction that occurred on Monday, March 17th. The shares were sold at an average price of $6.90, for a total transaction of $130,030.50. Following the sale, the insider now directly owns 339,810 shares in the company, valued at approximately $2,344,689. This represents a 5.25 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Company insiders own 6.60% of the company's stock.

LifeStance Health Group Trading Down 1.4 %

Shares of LFST opened at $5.73 on Friday. LifeStance Health Group, Inc. has a fifty-two week low of $4.64 and a fifty-two week high of $8.61. The business has a 50-day moving average of $6.70 and a 200 day moving average of $7.25. The firm has a market cap of $2.23 billion, a P/E ratio of -22.04 and a beta of 1.30. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.32 and a current ratio of 1.32.

Analyst Upgrades and Downgrades

A number of brokerages recently commented on LFST. William Blair reiterated an "outperform" rating on shares of LifeStance Health Group in a report on Friday, February 28th. Canaccord Genuity Group initiated coverage on shares of LifeStance Health Group in a report on Thursday, April 3rd. They issued a "buy" rating and a $8.00 price target on the stock. Finally, KeyCorp assumed coverage on shares of LifeStance Health Group in a report on Tuesday, April 8th. They set an "overweight" rating and a $9.00 price objective for the company. One analyst has rated the stock with a sell rating, one has given a hold rating, three have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $8.30.

LifeStance Health Group Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.

Want to see what other hedge funds are holding LFST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LifeStance Health Group, Inc. (NASDAQ:LFST - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.